So-Young International Inc.
$2.9
▲
4.36%
2026-04-21 09:42:00
www.soyoung.com
NCM: SY
Explore So-Young International Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$283.61 M
Current Price
$2.9
52W High / Low
$6.28 / $0.74
Stock P/E
—
Book Value
$2.25
Dividend Yield
0%
ROCE
-4.01%
ROE
-13.61%
Face Value
—
EPS
$-0.35
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
—
Beta
2.17
Debt / Equity
17.96
Current Ratio
1.89
Quick Ratio
2.5
Forward P/E
-10.53
Price / Sales
0.17
Enterprise Value
$-257.63 M
EV / EBITDA
1.17
EV / Revenue
-0.17
Rating
Strong Buy
Target Price
$7.61
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 2. | HealthEquity, Inc. | $83.22 | 33.83 | $7.04 B | — | 10.16% | 10.19% | $116.65 / $72.76 | $24.79 |
| 3. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 4. | Schrödinger, Inc. | $12.8 | — | $944.96 M | — | -31.08% | -26.29% | $27.63 / $10.95 | $4.94 |
| 5. | Veeva Systems Inc. | $165.91 | 30.52 | $27.21 B | — | 12.48% | 13.93% | $310.5 / $148.05 | $44.05 |
| 6. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 7. | Zhongchao Inc. | $2.06 | — | $7.52 M | — | -1.4% | -24.88% | $12.18 / $1.44 | $6.39 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | — | 386.67 M | 378.75 M | 297.27 M | 369.21 M | 371.82 M |
| Operating Profit | — | -72.71 M | -47.11 M | -43.41 M | -59.06 M | 4.68 M |
| Net Profit | — | -64.28 M | -36.04 M | -33.14 M | -607.58 M | 20.35 M |
| EPS in Rs | -1.08 | -0.76 | -0.43 | -0.39 | -7.18 | 0.24 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 1.47 B | 1.5 B | 1.26 B | 1.69 B |
| Operating Profit | -84.48 M | -61.05 M | -102.81 M | 33.31 M |
| Net Profit | -589.53 M | 21.28 M | -65.55 M | -8.37 M |
| EPS in Rs | -6.97 | 0.25 | -0.77 | -0.1 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 2.74 B | 3.21 B | 3.2 B | 3.33 B |
| Total Liabilities | 776.43 M | 653.25 M | 590 M | 813.33 M |
| Equity | 1.84 B | 2.44 B | 2.5 B | 2.45 B |
| Current Assets | 1.72 B | 1.72 B | 1.92 B | 2.03 B |
| Current Liabilities | 630.21 M | 540.42 M | 538.04 M | 712.4 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -25.63 M | 22.5 M | -112.87 M | 84.29 M |
| Investing CF | 257.04 M | -202.61 M | -572.21 M | 339.82 M |
| Financing CF | -21.51 M | -100.02 M | -13.59 M | -216.74 M |
| Free CF | -88.18 M | -28.68 M | -128.58 M | 39.23 M |
| Capex | -62.55 M | -51.18 M | -15.71 M | -45.06 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -2.09% | 19.09% | -25.68% | — |
| Earnings Growth % | -2870.33% | 132.46% | -683.11% | — |
| Profit Margin % | -40.19% | 1.42% | -5.21% | -0.49% |
| Operating Margin % | -5.76% | -4.08% | -8.17% | 1.97% |
| Gross Margin % | 61.3% | 63.66% | 68.73% | 80.63% |
| EBITDA Margin % | -2.63% | -1% | -4.43% | 3.75% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-04-08 | $0.027 |
| 2024-04-11 | $0.06 |
Stock Splits
No stock split history available.